Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Malignant Neoplasms of Digestive Organs 1 Advanced Nonhematologic Malignancies 1

Interventions

Dexamethasone 14 Rituximab 6 Cytarabine 5 venetoclax 4 Lenalidomide 4 Bortezomib 4 Bendamustine Hydrochloride 4 selinexor 3 pomalidomide 3 pembrolizumab 3 ibrutinib 3 fludarabine 3 carfilzomib 3 Paclitaxel 3 Gemcitabine 3 Drug Therapy 3 Cyclophosphamide 3 Calcium Dobesilate 3 ixazomib 2 gilteritinib 2 fludarabine phosphate 2 elotuzumab 2 daratumumab 2 belinostat 2 Tablets 2 Surveys and Questionnaires 2 Panobinostat 2 Oxaliplatin 2 Granulocyte Colony-Stimulating Factor 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Recurrence × MLN 8237 × Clear all

NCT02780011 2018-07-27

AD3LE

The Methodist Hospital Research Institute

Phase 1 Withdrawn

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡